x
Filter:
Filters applied
- Oncology
- Research ArticleRemove Research Article filter
- Carver, Brett SRemove Carver, Brett S filter
Publication Date
Please choose a date range between 2016 and 2018.
Author
- Sheinfeld, Joel5
- Assel, Melissa2
- Bajorin, Dean2
- Bajorin, Dean F2
- Bosl, George2
- Bosl, George J2
- Feldman, Darren2
- Feldman, Darren R2
- Motzer, Robert2
- Motzer, Robert J2
- Sjoberg, Daniel D2
- Bazzi, Wassim M1
- Becerra, Maria F1
- Bernstein, Melanie1
- Chevinsky, Michael1
- Dowling, Catherine M1
- Feifer, Andrew1
- Kopp, Ryan P1
- Meeks, Joshua J1
- Miller, Mariam Imnadze1
- Musser, John E1
- Pietzak, Eugene J1
- Recabal, Pedro1
- Rosenzweig, Barak1
Oncology
5 Results
- Oncology
Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.
UrologyVol. 124p174–178Published online: October 5, 2018- Mariam Imnadze Miller
- Andrew Feifer
- Darren R. Feldman
- Brett S. Carver
- George J. Bosl
- Robert J. Motzer
- and others
Cited in Scopus: 7To characterize clinical and pathologic outcomes of cisplatin-refractory or relapsed germ cell tumor (GCT) patients who underwent retroperitoneal lymph node dissection (RPLND) following salvage chemotherapy with either conventional or high dose regimens. - Oncology
Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor
UrologyVol. 118p114–118Published online: April 25, 2018- Eugene J. Pietzak
- Melissa Assel
- Maria F. Becerra
- Daniel Tennenbaum
- Darren R. Feldman
- Dean F. Bajorin
- and others
Cited in Scopus: 4To evaluate the oncologic outcomes and histologic concordance of postchemotherapy residual liver mass resection with postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). - Oncology
Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen
UrologyVol. 114p133–138Published online: February 2, 2018- Catherine M. Dowling
- Melissa Assel
- John E. Musser
- Joshua J. Meeks
- Daniel D. Sjoberg
- George Bosl
- and others
Cited in Scopus: 9To determine the pathologic findings and clinical outcome of patients with pure embryonal carcinoma (EC) of the testis who were diagnosed with testis cancer from January 1989 to January 2013 who underwent an orchiectomy, cisplatin-based chemotherapy and a postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). - Oncology
Malignant Mesothelioma of the Tunica Vaginalis Testis: Outcomes Following Surgical Management Beyond Radical Orchiectomy
UrologyVol. 107p166–170Published online: April 14, 2017- Pedro Recabal
- Barak Rosenzweig
- Wassim M. Bazzi
- Brett S. Carver
- Joel Sheinfeld
Cited in Scopus: 13To describe clinical management and outcomes of a cohort of patients with malignant mesothelioma of the tunica vaginalis testis (MMTVT) who received treatments beyond radical orchiectomy. - Oncology
Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy
UrologyVol. 103p154–160Published online: November 2, 2016- Ryan P. Kopp
- Michael Chevinsky
- Melanie Bernstein
- George Bosl
- Robert Motzer
- Dean Bajorin
- and others
Cited in Scopus: 8To characterize the incidence, presentation, management, and relapse of a large population of bilateral testicular germ cell tumors (TGCT) from a single institution.